Feature | March 09, 2010| Dave Fornell

Clinton Boosts Stent Awareness Among General Public

How is your Hospital Using Telecardiology?

The general public usually does not take a big interest in cardiology or the interventional devices used to treat cardiac conditions until a family member or someone famous makes headlines due to a cardiac condition. Stents were brought back to mainstream national and international headlines recently after former President Bill Clinton received two stents at New York Presbyterian Hospital.

He was admitted to the hospital Feb. 11 with chest pains and treated in the cath lab the same day. Clinton, 63, previously underwent a successful quadruple cardiac bypass surgery to open four blocked arteries in 2004.

Invatec Sold to Medtronic

Medtronic recently signed an agreement to acquire Italian-based Invatec, a large European cath lab device maker that specializes in peripheral interventions. The deal will greatly expand Medtronic’s peripheral artery disease (PAD) product offerings and its product lines in Europe.

In Europe, Invatec is the only company to bring four drug-eluting balloons to market, covering the coronaries and lower-extremity vessels. It offers three drug-eluting balloons in Europe. It is also a pioneer in the development and commercialization of lesion-specific solutions, including therapies for below-the-knee and carotid artery disease.

The acquisition includes Fogazzi, an Italian company that provides polymer technology to Invatec, and Krauth Cardiovascular, which distributes Invatec products in Germany. Medtronic made an initial payment of $350 million for the company in January, and additional payments of up to $150 million will be made for Invatec’s achievement of specific milestones.

What are Your Thoughts on Telemedicine?

One area where there seems to be a shortage of information is how to develop telecardiology programs. A Web search will produce a lot of discussion on theory for creating such programs, but there is little concrete information. Clinicians and hospitals want to know how to put these programs together, how reimbursement works, where to find equipment, technical trouble shooting and how to overcome the multitude of HIPPA compliance issues.

With the changing nature of electronic medical records (EMRs) and PACS systems to Web-based platforms, and software and device makers increasingly embracing vendor-neutral solutions, the ability to create telecardiology programs is become much more attainable. With the federal government’s demand that all healthcare providers migrate to EMRs and its initiatives to help drive down healthcare costs, telecardiology programs make sense. Rural healthcare providers can partner with larger hospitals hundreds of miles away to allow their patients easy access to cardiac or vascular specialists.

The federal government and the military already use telemedicine to connect remote bases and Native American reservations to top-of-the-line care. In recent years, several hospitals specializing in congenital heart conditions have also created telecardiology programs to network regional hospitals. These programs quickly connect patients with specialists, speeds the screening of patients, and saves the patients time and days off work for travel.

Diagnostic and Invasive Cardiology plans to explore some of the questions in the May/June issue. I would love to hear from clinicians involved with telemedicine programs at their hospitals to see how their programs are set up and operated. You are welcome to send me an e-mail or give me a call.

We welcome your comments on the topics found in Diagnostic & Invasive Cardiology.
Please send your thoughts to [email protected]

Related Content

Intact Vascular, TOBA II study, Tack Endovascular System

Image courtesy of Intact Vascular

News | Peripheral Arterial Disease (PAD)| October 01, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and...
Cook Medical, Zilver PTX, Japan PMS study, CIRSE 2015, two-year results

Image courtesy of Cook Medical

News | Stents Peripheral| October 01, 2015
Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two-year results of the...
Stentys, CE Mark for self-apposing stent, lower limb artery disease, below-the-knee arteries, critical limb ischemia, PES BTK-70 trial

Image courtesy of Stentys

News | Stents Peripheral| October 01, 2015
Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the-knee (BTK) arteries...
Eluvia drug-eluting vascular stent system, 12-month primary patency, Boston Scientific, MAJESTIC trial, CIRSE

Image courtesy of Boston Scientific

News | Stents Peripheral| September 28, 2015
New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific Eluvia drug-eluting...
biomimics, 3D stent
News | Peripheral Arterial Disease (PAD)| August 28, 2015
August 28, 2015 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania and second in th
News | Cath Lab| August 26, 2015
August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report in
Boston Scientific, Innova vascular self-expanding stent system, FDA approval, peripheral artery disease, PAD
Technology | Stents Peripheral| August 20, 2015
Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Innova Vascular Self-...
Hansen Medical, Magellan 10 French Robotic Catheter, FDA 510(k) clearance
Technology | Robotic Systems| July 29, 2015
The Magellan 10 French Robotic Catheter from Hansen Medical is indicated for use in the peripheral vasculature.
CSI, ViperWire Advance Peripheral Guide Wire with Flex Tip, Stealth, Diamondback

Diamondback 360 Peripheral OAS image courtesy of Cardiovascular Systems Inc.

Technology | Atherectomy Devices| July 22, 2015
Cardiovascular Systems Inc. announced that it has received U.S. Food and Drug Administration (FDA) clearance for its...
Veryan Medical, BioMimics 3D femoropopliteal stent, MIMICS-2 study, PAD
News | Stents Peripheral| July 17, 2015
Veryan Medical announced that the first subject has been enrolled in their MIMICS-2 study at Universitäts-Herzzentrum...
Overlay Init